Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MERCK AS NUMBER ONE: VITAL STATISTICS

Executive Summary

A synopsis of the areas in which Merck holds the top position in the drug industry. The information is taken from the Nov. 3 presentation by Merck Chairman Vagelos to the New York Society of Security Analysts. * World pharmaceutical market -- number one with a less than 5% total marketshare * U.S. pharmaceutical market -- sales leader for the ninth consecutive year and expecting to "substantially increase" its lead over runner-up Glaxo in 1988 * U.S. drug companies in Europe -- sales leader; plans to be the leading company in Europe by 1992 * Injectable antibiotics -- worldwide leader, Primaxin has surpassed Mefoxin, "for some years the world leader" * Compound annual return to shareholders (stock appreciation and dividends) -- during 1986-1988, 52%, "by far the best in our industry"
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS014570

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel